YOUR SEARCH FOR Text 110 RESULTS
31 of Total
0000879169-24-000149 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Jul 30, 2024 Document Date Jun 30, 2024 Form Description …
32 of Total
0000879169-24-000172 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Oct 29, 2024 Document Date Sep 30, 2024 Form Description …
33 of Total
0000879169-25-000056 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Apr 29, 2025 Document Date Mar 31, 2025 Form Description …
34 of Total
0000879169-25-000103 | 10-Q | Incyte
… Reports SEC Filings SEC Filing Details Document Details Form 10-Q Filing Date Jul 29, 2025 Document Date Jun 30, 2025 Form Description …
35 of Total
Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… and vitiligo – Multiple positive data readouts from dermatology portfolio at AAD and EHSF … results demonstrate continued year-over-year double-digit revenue growth driven by Jakafi, …
36 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… (FL) in combination with rituximab and lenalidomide, respectively – Bill Meury appointed as … normalization of platelet counts across all dose levels and importantly, a reduction in …
37 of Total
Compliance & Transparency | Incyte.com
… to honor that trust in everything we do. Bill Meury, President and Chief Executive … Transparency Close Open U.S. Sunshine Act Colorado Disclosure Act Compassionate Use …
38 of Total
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs |
… revenues growing 25% year over year led by double-digit Jakafi ® (ruxolitinib) growth and … an overall response rate (ORR) of 74% at the dose of 0.3 mg/kg administered every two weeks. …
39 of Total
Incyte Involved | Supporting Our Communities | Incyte.com
… Giving Foundation provides charitable donations to publicly funded 501(c) (3) … Charitable Giving Foundation only provides donations to publicly funded organizations in …
40 of Total
Culture & Careers | Incyte.com
… to patients faster, and the work that we do in drug development plays a significant role … pushing the envelope as far as innovation, doing science that hasn’t been done before…It’s …